In addition to high levels of D-2HG, these epigenetic modulations in IDH-mutant gliomas result in widespread gene expression changes that can further alter the metabolic profile of these tumors, which are also potentially detectable using MR spectroscopy (for reviews, see [12,13]). This evidence concerns the gene IDH2 and central nervous system cancer.